Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)

Completed · Not applicable

Conditions studied: Venous Reflux

In brief

The VenaSeal Closure system offers an outpatient treatment option for the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation. VenaSeal is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (DUS).

Key facts

Study ID
NCT02585726
Run by
Lake Washington Vascular
People needed
50
Starts
2015-10-01
Expected to finish
2017-07-01
Last updated by the study team
2018-03-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.